Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma

The low resection and high recurrence rates in hepatocellular carcinoma (HCC) are the major challenges to improving prognosis. Neoadjuvant and conversion therapies are underlying strategies to overcome these challenges. To date, no guideline or consensus has been published on the neoadjuvant and con...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 27; no. 47; pp. 8069 - 8080
Main Authors Zhao, Hai-Tao, Cai, Jian-Qiang
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 21.12.2021
Subjects
Carcinoma, Hepatocellular - therapy
Consensus
Expert Consensus
Humans
Liver Neoplasms - therapy
Neoadjuvant Therapy - adverse effects
Prognosis
Conversion therapy
Neoadjuvant therapy
Hepatocellular carcinoma
Consensus
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first